ProCE Banner Activity


Getting Ahead on Migraine Management: The Place for Novel Options

Text Module

This CE/CME BriefCase emphasizes the importance of diagnosing and treating migraine, with a focus on novel treatment options and how to incorporate these into clinical practice.

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurse Practitioners: 1.00 Nursing contact hours, includes 1.00 hour of pharmacotherapy credit

Released: January 23, 2023

Expiration: January 22, 2024

No longer available for credit.



Jessica Ailani

Jessica Ailani, MD

MedStar Georgetown Headache Center
Professor of Clinical Neurology
Department of Neurology
MedStar Georgetown University Hospital
Washington, DC

Provided by

ProCE Banner


This program is supported by an educational grant from

Biohaven Pharmaceuticals, Inc

Target Audience

Primary Care NPs and PAs

Learning Objectives

After completing this activity, participants should be better able to:

  • Apply recommended tools and criteria to differentially diagnose migraine

  • Implement current evidence-based strategies for the acute treatment and prevention of migraine

  • Formulate treatment plans for the appropriate use of novel migraine therapies in clinical practice


All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PACE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Jessica Ailani, MD: consultant/advisor/speaker: AbbVie, Aeon, Amgen, Biohaven, GlaxoSmithKline, Impel, Lilly, Lundbeck, Miravo, Nesos, Neurolief, Pfizer, Satsuma, Teva, Theranica; researcher: AbbVie, Biohaven, Lilly, Satsuma, Zosano; individual publicly traded stock/stock options: Ctrlm.

Stephanie Jalaba, MMS, PA-C, has no relevant financial relationships to report.

Maureen Moriarty, DNP, ANP-BC: consultant/advisor/speaker: AbbVie, Amgen, Biohaven, Impel, Lilly; researcher: Teva

The planners and content peer reviewers from Partners for Advancing Clinical Education and Practicing Clinicians Exchange do not have any relevant financial relationships to disclose.

Instructions for Credit

Learners wishing to earn CE/CME credit must:

  1. View the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete the evaluation form

The estimated time to complete this activity is 1.00 hour.

Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of 65%.


This program has been made available online.


The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Partners for Advancing Clinical Education, Practicing Clinicians Exchange, or any educational supporter.


Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


ANCC Credit Designation

Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit


AAPA Credit Designation

Joint AccreditationPartners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until January 22, 2024. PAs should only claim credit commensurate with the extent of their participation.



IPCE Credit Designation
IPCE This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.